PI
-
Cost-utility analysis of cerebrospinal fluid versus blood biomarkers for early detection of Alzheimer's disease and mild cognitive impairment in Thailand: a modeling study
Leelahavarong, P., Prawjaeng, J., Angkab, P., Wongkom, N., Scheltens, P., Srinonprasert, V. & Senanarong, V., Dec 2026, In: BMC health services research. 26, 1, 685.Research output: Contribution to Journal › Article › Academic › peer-review
-
Connectome-guided personalization of optimal tDCS intervention selection in Alzheimer's disease: A modeling study
Luppi, J. J., Koomen, A. P., Stam, C. J., Scheltens, P. & de Haan, W., 1 Aug 2026, In: eNeuro. 13, 8, ENEURO.0407-25.2026.Research output: Contribution to Journal › Article › Academic › peer-review
-
Analytical framing of Amyloid beta monoclonal antibody trials in Alzheimer's disease can obscure clinical effects
Tijms, B. M., van Harten, A. C., Carillo, M. C., Scheltens, P. & Vijverberg, E. G. B., 1 Jul 2026, In: Alzheimer's and Dementia. 22, 7, e71646.Research output: Contribution to Journal › Comment / Letter to the editor › Academic
- All publications